Baseline (A) | 6 months (B) | 12 months (C) | P value A vs B | P value A vs C | |
MCS | 48.5±10.2 | 50.7±9.9 | 51.3±9.9 | <0.001 | <0.001 |
n | 674 | 674 | 674 | ||
MCS in women | 47.1±10.4 | 48.9±9.8 | 49.6±10.2 | 0.03 | 0.003 |
n | 329 | 329 | 329 | ||
MCS in men | 49.9±9.9 | 52.4±9.7 | 52.9±9.2 | 0.001 | <0.001 |
n | 345 | 345 | 345 | ||
MCS in persons with a baseline MCS ≤45 | 36.9±6.0 | 43.4±9.4 | 44.2±9.9 | <0.001 | <0.001 |
n | 235 | 235 | 235 | ||
MCS in women with a baseline MCS ≤45 | 36.9±6.0 | 42.9±9.3 | 43.6±10.4 | <0.001 | <0.001 |
n | 137 | 137 | 137 | ||
MCS in men with a baseline MCS ≤45 | 37.0±6.0 | 44.0±9.6 | 45.2±9.2 | <0.001 | <0.001 |
n | 98 | 98 | 98 | ||
MCS in persons with a baseline MCS >45 | 54.8±5.5 | 54.6±7.6 | 55.1±7.4 | 0.87 | 0.87 |
n | 439 | 439 | 439 | ||
MCS in persons with type 1 DM | 48.3±10.3 | 50.6±10.0 | 51.5±9.9 | <0.001 | <0.001 |
n | 527 | 527 | 527 | ||
MCS in persons with type 2 DM | 48.5±10.2 | 50.4±9.7 | 50.5±9.4 | 0.49 | 0.46 |
n | 98 | 98 | 98 | ||
MCS in persons with an HbA1c ≤53 mmol/mol | 48.4±10.5 | 51.7±10.0 | 51.9±9.9 | 0.005 | 0.004 |
n | 176 | 176 | 176 | ||
MCS in persons with an HbA1c >53 mmol/mol | 48.6±10.1 | 50.4±9.8 | 51.2±9.8 | 0.01 | 0.001 |
n | 497 | 497 | 497 | ||
MCS in persons with HbA1c >64 mmol/mol | 48.9±10.2 | 50.1±9.9 | 51.1±10.3 | 0.36 | 0.04 |
n | 251 | 251 | 251 |
Data are presented as mean±SD.
DM, diabetes mellitus; FSL-FGM, FreeStyle Libre flash glucose monitoring.